NDRA
Endra Life Sciences·NASDAQ
--
--(--)
--
--(--)
4.76 / 10
Netural
Fund flows are surprisingly constructive (score 7.52/10) with net inflows across block, small, medium, large, and extra-large sizes, despite the negative trend labels. Analyst sentiment is unanimously Strong Buy, though based on a single analyst with a low 25% historical win rate, limiting conviction.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-08
InstitutionAscendiant Capital
Times predicted4
Historical Win Rate25.0%
What is the market sentiment for NDRA?
- NDRA holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.76/10 (Netural).
